Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 35, Issue 5, Pages 497–503
http://dx.doi.org/10.1155/2013/969473
Research Article

Activin A and Follistatin as Biomarkers for Ectopic Pregnancy and Missed Abortion

1Department of Obstetrics and Gynecology, Faculty of Medicine, School of Health Sciences, University of Thessaly, 41110 Biopolis, Larissa, Greece
2Division of Pediatric—Adolescent Gynecology and Reconstructive Surgery, 2nd Department of Obstetrics and Gynecology, University of Athens, Medical School, Aretaieion Hospital, 11528 Athens, Greece
3Department of Microbiology Medical School, University of Athens, 11527 Athens, Greece
4Department of Hygiene and Epidemiology, Faculty of Medicine, University of Thessaly, 41221 Larissa, Greece

Received 30 June 2013; Accepted 3 September 2013

Academic Editor: Irene Rebelo

Copyright © 2013 Alexandros Daponte et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Cartwright, W. C. Duncan, H. O. D. Critchley, and A. W. Horne, “Serum biomarkers of tubal ectopic pregnancy: current candidates and future possibilities,” Reproduction, vol. 138, no. 1, pp. 9–22, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. M. E. Rausch, M. D. Sammel, P. Takacs, K. Chung, A. Shaunik, and K. T. Barnhart, “Development of a multiple marker test for ectopic pregnancy,” Obstetrics and Gynecology, vol. 117, no. 3, pp. 573–582, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Daponte, S. Pournaras, E. Zintzaras et al., “The value of a single combined measurement of VEGF, glycodelin, progesterone, PAPP-A, HPL and LIF for differentiating between ectopic and abnormal intrauterine pregnancy,” Human Reproduction, vol. 20, no. 11, pp. 3163–3166, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. J. L. Shaw, E. P. Diamandis, A. Horne, K. Barnhart, T. Bourne, and I. E. Messinis, “Ectopic pregnancy,” Clinical Chemistry, 2012. View at Google Scholar
  5. M. Wakatsuki, Y. Shintani, M. Abe, Z.-H. Liu, K. Shitsukawa, and S. Saito, “Immunoradiometric assay for follistatin: serum immunoreactive follistatin levels in normal adults and pregnant women,” The Journal of Clinical Endocrinology and Metabolism, vol. 81, no. 2, pp. 630–634, 1996. View at Publisher · View at Google Scholar · View at Scopus
  6. T. K. Woodruff, P. Sluss, E. Wang, I. Janssen, and M. S. Mersol-Barg, “Activin A and follistatin are dynamically regulated during human pregnancy,” The Journal of Endocrinology, vol. 152, no. 2, pp. 167–174, 1997. View at Google Scholar · View at Scopus
  7. E. M. Wallace, B. Marjono, K. Tyzack, and S. Tong, “First trimester levels of inhibins and activin A in normal and failing pregnancies,” Clinical Endocrinology, vol. 60, no. 4, pp. 484–490, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Prakash, S. Laird, E. Tuckerman, T. C. Li, and W. L. Ledger, “Inhibin A and activin A may be used to predict pregnancy outcome in women with recurrent miscarriage,” Fertility and Sterility, vol. 83, no. 6, pp. 1758–1763, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. R. L. Jones, J. K. Findlay, P. G. Farnworth, D. M. Robertson, E. Wallace, and L. A. Salamonsen, “Activin A and inhibin a differentially regulate human uterine matrix metalloproteinases: Potential interactions during decidualization and trophoblast invasion,” Endocrinology, vol. 147, no. 2, pp. 724–732, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. P. Florio, F. M. Severi, C. Bocchi et al., “Single serum activin A testing to predict ectopic pregnancy,” The Journal of Clinical Endocrinology and Metabolism, vol. 92, no. 5, pp. 1748–1753, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Johns, S. Muttukrishna, M. Lygnos, N. Groome, and E. Jauniaux, “Maternal serum hormone concentrations for prediction of adverse outcome in threatened miscarriage,” Reproductive BioMedicine Online, vol. 15, no. 4, article no. 2969, pp. 413–421, 2007. View at Google Scholar · View at Scopus
  12. E. Kirk, A. T. Papageorghiou, B. Van Calster et al., “The use of serum inhibin A and activin A levels in predicting the outcome of 'pregnancies of unknown location',” Human Reproduction, vol. 24, no. 10, pp. 2451–2456, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. P. Florio, F. M. Reis, R. Battista et al., “Serum activin A levels are lower in tubal than intrauterine spontaneously conceived pregnancies,” Gynecological Endocrinology, vol. 27, no. 6, pp. 391–395, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Warrick, A. Gronowski, C. Moffett, Q. Zhao, E. Bishop, and A. Woodworth, “Serum activin A does not predict ectopic pregnancy as a single measurement test, alone or as part of a multi-marker panel including progesterone and hCG,” Clinica Chimica Acta, vol. 413, no. 7-8, pp. 707–711, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. D. M. de Kretser, L. M. Foulds, M. Hancock, and D. M. Robertson, “Partial characterization of inhibin, activin, and follistatin in the term human placenta,” The Journal of Clinical Endocrinology and Metabolism, vol. 79, no. 2, pp. 502–507, 1994. View at Publisher · View at Google Scholar · View at Scopus
  16. F. Petraglia, A. Gallinelli, D. de Vita, K. Lewis, L. Mathews, and W. Vale, “Activin at parturition: changes of maternal serum levels and evidence for binding sites in placenta and fetal membranes,” Obstetrics and Gynecology, vol. 84, no. 2, pp. 278–282, 1994. View at Google Scholar · View at Scopus
  17. S. Luisi, P. Florio, D. D'Antona et al., “Maternal serum inhibin A levels are a marker of a viable trophoblast in incomplete and complete miscarriage,” European The Journal of Endocrinology, vol. 148, no. 2, pp. 233–236, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. P. Florio, S. Luisi, P. Ciarmela, F. M. Severi, C. Bocchi, and F. Petraglia, “Inhibins and activins in pregnancy,” Molecular and Cellular Endocrinology, vol. 225, no. 1-2, pp. 93–100, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Muttukrishna, E. Jauniaux, N. Greenwold et al., “Circulating levels of inhibin A, activin A and follistatin in missed and recurrent miscarriages,” Human Reproduction, vol. 17, no. 12, pp. 3072–3078, 2002. View at Google Scholar · View at Scopus
  20. P. Florio, M. Gabbanini, L. E. Borges et al., “Activins and related proteins in the establishment of pregnancy,” Reproductive Sciences, vol. 17, no. 4, pp. 320–330, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Muttukrishna, C. Bearfield, J. Johns, and E. Jauniaux, “Inhibin, activin, follistatin, activin receptors and β-glycan gene expression in the villous tissue of miscarriage patients,” Molecular Human Reproduction, vol. 10, no. 11, pp. 793–798, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. B. A. Refaat, A. O. Bahathiq, S. Sockanathan, R. L. Stewart, M. Wells, and W. L. Ledger, “Production and localization of activins and activin type IIA and IIB receptors by the human endosalpinx,” Reproduction, vol. 128, no. 2, pp. 249–255, 2004. View at Google Scholar · View at Scopus
  23. X. Wen, A. J. Tozer, D. Li, S. M. Docherty, T. Al-Shawaf, and R. K. Iles, “Human granulosa-lutein cell in vitro production of progesterone, inhibin A, inhibin B, and activin A are dependent on follicular size and not the presence of the oocyte,” Fertility and Sterility, vol. 89, no. 5, pp. 1406–1413, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. C. Bearfield, E. Jauniaux, N. Groome, I. L. Sargent, and S. Muttukrishna, “The secretion and effect of inhibin A, activin A and follistatin on first-trimester trophoblasts in vitro,” European The Journal of Endocrinology, vol. 152, no. 6, pp. 909–916, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. R. L. Jones, L. A. Salamonsen, Y. C. Zhao, J.-F. Ethier, A. E. Drummond, and J. K. Findlay, “Expression of activin receptors, follistatin and betaglycan by human endometrial stromal cells; consistent with a role for activins during decidualization,” Molecular Human Reproduction, vol. 8, no. 4, pp. 363–374, 2002. View at Google Scholar · View at Scopus
  26. M. Birdsall, W. Ledger, N. Groome, H. Abdalla, and S. Muttukrishna, “Inhibin A and activin A in the first trimester of human pregnancy,” The Journal of Clinical Endocrinology and Metabolism, vol. 82, no. 5, pp. 1557–1560, 1997. View at Google Scholar · View at Scopus
  27. G. M. Lockwood, W. L. Ledger, D. H. Barlow, N. P. Groome, and S. Muttukrishna, “Measurement of inhibin and activin in early human pregnancy: demonstration of fetoplacental origin and role in prediction of early- pregnancy outcome,” Biology of Reproduction, vol. 57, no. 6, pp. 1490–1494, 1997. View at Google Scholar · View at Scopus
  28. S. Muttukrishna, P. G. Knight, N. P. Groome, C. W. G. Redman, and W. L. Ledger, “Activin A and inhibin A as possible endocrine markers for preeclampsia,” The Lancet, vol. 349, no. 9061, pp. 1285–1288, 1997. View at Google Scholar · View at Scopus
  29. M. E. Schneider-Kolsky, U. Manuelpillai, K. Waldron, A. Dole, and E. M. Wallace, “The distribution of activin and activin receptors in gestational tissues across human pregnancy and during labour,” Placenta, vol. 23, no. 4, pp. 294–302, 2002. View at Publisher · View at Google Scholar · View at Scopus
  30. P. A. Fowler, L. W. Evans, N. P. Groome, A. Templeton, and P. G. Knight, “A longitudinal study of maternal serum inhibin-A inhibin-B, activin-A activin-AB, pro-αC and follistatin during pregnancy,” Human Reproduction, vol. 13, no. 12, pp. 3530–3536, 1998. View at Publisher · View at Google Scholar · View at Scopus
  31. A. E. O'Connor, J. R. McFarlane, S. Hayward, T. Yohkaichiya, N. P. Groome, and D. M. De Kretser, “Serum activin A and follistatin concentrations during human pregnancy: a cross-sectional and longitudinal study,” Human Reproduction, vol. 14, no. 3, pp. 827–832, 1999. View at Google Scholar · View at Scopus
  32. M. Schneider-Kolsky, D. D'Antona, L. W. Evans et al., “Maternal serum total activin A and follistatin in pregnancy and parturition,” British Journal of Obstetrics and Gynaecology, vol. 107, no. 8, pp. 995–1000, 2000. View at Google Scholar · View at Scopus
  33. E. P. Tierney and L. C. Giudice, “Role of activin A as a mediator of in vitro endometrial stromal cell decidualization via the cyclic adenosine monophosphate pathway,” Fertility and Sterility, vol. 81, no. 1, pp. 899–903, 2004. View at Publisher · View at Google Scholar · View at Scopus
  34. T. R. Kumar, “Too many follistatins: racing inside and getting out of the cell,” Endocrinology, vol. 146, no. 12, pp. 5048–5051, 2005. View at Publisher · View at Google Scholar · View at Scopus
  35. V. Maguer-Satta, L. Bartholin, S. Jeanpierre et al., “During hematopoiesis, expression of FLRG, a novel activin A ligand, is regulated by TGF-β,” Experimental Hematology, vol. 29, no. 3, pp. 301–308, 2001. View at Publisher · View at Google Scholar · View at Scopus
  36. G. J. Burton, E. Jauniaux, and A. L. Watson, “Maternal arterial connections to the placental intervillous space during the first trimester of human pregnancy: the boyd collection revisited,” The American Journal of Obstetrics and Gynecology, vol. 181, no. 3, pp. 718–724, 1999. View at Publisher · View at Google Scholar · View at Scopus
  37. J. Warrick, A. Gronowski, C. Moffett, Q. Zhao, E. Bishop, and A. Woodworth, “Serum activin A does not predict ectopic pregnancy as a single measurement test, alone or as part of a multi-marker panel including progesterone and hCG,” Clinica Chimica Acta, vol. 413, no. 7-8, pp. 707–711, 2012. View at Publisher · View at Google Scholar · View at Scopus